• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依诺沙星抑制前列腺癌细胞生长,并能有效恢复 miRNA 加工。

Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.

机构信息

Cancer Epigenetics Group, Research Center of the Portuguese Oncology Institute, Porto, Portugal.

出版信息

Epigenetics. 2013 May;8(5):548-58. doi: 10.4161/epi.24519. Epub 2013 Apr 17.

DOI:10.4161/epi.24519
PMID:23644875
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3741225/
Abstract

Prostate cancer (PCa) is one of the most incident malignancies worldwide. Although efficient therapy is available for early-stage PCa, treatment of advanced disease is mainly ineffective and remains a clinical challenge. microRNA (miRNA) dysregulation is associated with PCa development and progression. In fact, several studies have reported a widespread downregulation of miRNAs in PCa, which highlights the importance of studying compounds capable of restoring the global miRNA expression. The main aim of this study was to define the usefulness of enoxacin as an anti-tumoral agent in PCa, due to its ability to induce miRNA biogenesis in a TRBP-mediated manner. Using a panel of five PCa cell lines, we observed that all of them were wild type for the TARBP2 gene and expressed TRBP protein. Furthermore, primary prostate carcinomas displayed normal levels of TRBP protein. Remarkably, enoxacin was able to decrease cell viability, induce apoptosis, cause cell cycle arrest, and inhibit the invasiveness of cell lines. Enoxacin was also effective in restoring the global expression of miRNAs. This study is the first to show that PCa cells are highly responsive to the anti-tumoral effects of enoxacin. Therefore, enoxacin constitutes a promising therapeutic agent for PCa.

摘要

前列腺癌(PCa)是全球最常见的恶性肿瘤之一。尽管早期 PCa 有有效的治疗方法,但晚期疾病的治疗主要无效,仍然是一个临床挑战。 microRNA(miRNA)失调与 PCa 的发生和发展有关。事实上,有几项研究报告称,miRNA 在 PCa 中广泛下调,这凸显了研究能够恢复全局 miRNA 表达的化合物的重要性。本研究的主要目的是由于依诺沙星能够以 TRBP 介导的方式诱导 miRNA 生物发生,来定义依诺沙星作为 PCa 抗肿瘤剂的有用性。使用一组五种 PCa 细胞系,我们观察到它们全部为 TARBP2 基因的野生型,并表达 TRBP 蛋白。此外,原发性前列腺癌显示出正常水平的 TRBP 蛋白。值得注意的是,依诺沙星能够降低细胞活力,诱导细胞凋亡,引起细胞周期停滞,并抑制细胞系的侵袭性。依诺沙星还能有效恢复 miRNA 的全局表达。这项研究首次表明,PCa 细胞对依诺沙星的抗肿瘤作用高度敏感。因此,依诺沙星构成了治疗 PCa 的一种有前途的治疗剂。

相似文献

1
Enoxacin inhibits growth of prostate cancer cells and effectively restores microRNA processing.依诺沙星抑制前列腺癌细胞生长,并能有效恢复 miRNA 加工。
Epigenetics. 2013 May;8(5):548-58. doi: 10.4161/epi.24519. Epub 2013 Apr 17.
2
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing.小分子依诺沙星是一种癌症特异性生长抑制剂,通过增强 TAR RNA 结合蛋白 2 介导的 microRNA 加工起作用。
Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4394-9. doi: 10.1073/pnas.1014720108. Epub 2011 Feb 28.
3
Identification of a Novel TAR RNA-Binding Protein 2 Modulator with Potential Therapeutic Activity against Hepatocellular Carcinoma.鉴定新型 TAR RNA 结合蛋白 2 调节剂,具有潜在的肝细胞癌治疗活性。
J Med Chem. 2021 Jun 10;64(11):7404-7421. doi: 10.1021/acs.jmedchem.1c00018. Epub 2021 May 26.
4
A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function.人类癌症中的一种TARBP2突变会损害微小RNA加工和DICER1功能。
Nat Genet. 2009 Mar;41(3):365-70. doi: 10.1038/ng.317. Epub 2009 Feb 15.
5
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.微小RNA-466通过直接调控成骨转录因子RUNX2抑制前列腺癌的肿瘤生长和骨转移。
Cell Death Dis. 2017 Jan 26;8(1):e2572. doi: 10.1038/cddis.2017.15.
6
miR-199a-3p inhibits aurora kinase A and attenuates prostate cancer growth: new avenue for prostate cancer treatment.miR-199a-3p 抑制极光激酶 A 并减弱前列腺癌生长:前列腺癌治疗的新途径。
Am J Pathol. 2014 May;184(5):1541-9. doi: 10.1016/j.ajpath.2014.01.017. Epub 2014 Mar 11.
7
Expression of dicer and its related miRNAs in the progression of prostate cancer.Dicer及其相关微小RNA在前列腺癌进展中的表达
PLoS One. 2015 Mar 13;10(3):e0120159. doi: 10.1371/journal.pone.0120159. eCollection 2015.
8
Systematic Identification of MicroRNAs That Impact on Proliferation of Prostate Cancer Cells and Display Changed Expression in Tumor Tissue.系统鉴定影响前列腺癌细胞增殖并在肿瘤组织中表达改变的 microRNAs。
Eur Urol. 2016 Jun;69(6):1120-8. doi: 10.1016/j.eururo.2015.09.019. Epub 2015 Oct 20.
9
Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.染料木黄酮上调前列腺癌中的肿瘤抑制 microRNA-574-3p。
PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.
10
Iron homeostasis regulates the activity of the microRNA pathway through poly(C)-binding protein 2.铁稳态通过聚(C)结合蛋白 2 调节 microRNA 通路的活性。
Cell Metab. 2012 Jun 6;15(6):895-904. doi: 10.1016/j.cmet.2012.04.021. Epub 2012 May 24.

引用本文的文献

1
Repurposing fluoroquinolones as cancer chemosensitizers: a way to overcome cancer therapeutic bottleneck.将氟喹诺酮类药物重新用作癌症化疗增敏剂:一种克服癌症治疗瓶颈的方法。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Aug 11. doi: 10.1007/s00210-025-04508-x.
2
Anti-HIV-1 Effect of the Fluoroquinolone Enoxacin and Modulation of Pro-Viral hsa-miR-132 Processing in CEM-SS Cells.氟喹诺酮类药物依诺沙星对CEM-SS细胞的抗HIV-1作用及前体病毒hsa-miR-132加工的调控
Noncoding RNA. 2025 Jan 20;11(1):8. doi: 10.3390/ncrna11010008.
3
In Silico Evaluation of Some Computer-Designed Fluoroquinolone-Glutamic Acid Hybrids as Potential Topoisomerase II Inhibitors with Anti-Cancer Effect.一些计算机设计的氟喹诺酮-谷氨酸杂化物作为具有抗癌作用的潜在拓扑异构酶II抑制剂的计算机模拟评估
Pharmaceuticals (Basel). 2024 Nov 26;17(12):1593. doi: 10.3390/ph17121593.
4
Advances in the Synthesis and Biological Applications of Enoxacin-Based Compounds.依诺沙星类化合物的合成及生物应用进展。
Biomolecules. 2024 Nov 7;14(11):1419. doi: 10.3390/biom14111419.
5
Drug repurposing of fluoroquinolones as anticancer agents in 2023.2023年氟喹诺酮类药物作为抗癌剂的药物重新利用。
RSC Adv. 2024 Nov 20;14(50):37114-37130. doi: 10.1039/d4ra03571b. eCollection 2024 Nov 19.
6
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery.通过调节微小RNA加工机制发挥作用的新型抗卵巢癌喹诺酮衍生物
RSC Med Chem. 2024 Sep 27;16(1):98-124. doi: 10.1039/d4md00649f.
7
Genomic landscape and preclinical models of angiosarcoma.血管肉瘤的基因组图谱与临床前模型
Mol Oncol. 2025 Apr;19(4):965-983. doi: 10.1002/1878-0261.13744. Epub 2024 Oct 5.
8
LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer.LCP1 与免疫浸润相关:三阴性乳腺癌的预后标志物。
BMC Immunol. 2024 Jul 8;25(1):42. doi: 10.1186/s12865-024-00635-x.
9
Tetrahydroquinolinone derivatives exert antiproliferative effect on lung cancer cells through apoptosis induction.四氢喹啉酮衍生物通过诱导细胞凋亡发挥抗肺癌细胞增殖作用。
Sci Rep. 2022 Nov 9;12(1):19076. doi: 10.1038/s41598-022-23640-9.
10
Design, synthesis, and evaluation of fluoroquinolone derivatives as microRNA-21 small-molecule inhibitors.氟喹诺酮衍生物作为微小RNA-21小分子抑制剂的设计、合成及评估
J Pharm Anal. 2022 Aug;12(4):653-663. doi: 10.1016/j.jpha.2021.12.008. Epub 2022 Jan 3.

本文引用的文献

1
Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study.醋酸阿比特龙治疗转移性去势抵抗性前列腺癌:COU-AA-301 随机、双盲、安慰剂对照 3 期研究的最终总生存分析。
Lancet Oncol. 2012 Oct;13(10):983-92. doi: 10.1016/S1470-2045(12)70379-0. Epub 2012 Sep 18.
2
A changing landscape in castration-resistant prostate cancer treatment.去势抵抗性前列腺癌治疗领域的变化。
Front Endocrinol (Lausanne). 2012 Jul 18;3:85. doi: 10.3389/fendo.2012.00085. eCollection 2012.
3
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies.微小 RNA 在癌症中的作用:诊断和预后生物标志物以及治疗靶点。
Expert Opin Ther Targets. 2012 Apr;16 Suppl 2:S103-9. doi: 10.1517/14728222.2011.650632. Epub 2012 Mar 23.
4
Recent updates on the role of microRNAs in prostate cancer.近期关于 microRNAs 在前列腺癌中作用的研究进展。
J Hematol Oncol. 2012 Mar 14;5:9. doi: 10.1186/1756-8722-5-9.
5
miRNA-29b suppresses prostate cancer metastasis by regulating epithelial-mesenchymal transition signaling.miRNA-29b 通过调控上皮间质转化信号通路抑制前列腺癌转移。
Mol Cancer Ther. 2012 May;11(5):1166-73. doi: 10.1158/1535-7163.MCT-12-0100. Epub 2012 Mar 8.
6
MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.miRNA 在癌症中的失调:诊断、监测和治疗。全面综述。
EMBO Mol Med. 2012 Mar;4(3):143-59. doi: 10.1002/emmm.201100209. Epub 2012 Feb 20.
7
Non-coding RNAs in human disease.人类疾病中的非编码 RNA。
Nat Rev Genet. 2011 Nov 18;12(12):861-74. doi: 10.1038/nrg3074.
8
The therapeutic potential of microRNAs: disease modulators and drug targets.微小 RNA 的治疗潜力:疾病调节剂和药物靶点。
Pharm Res. 2011 Dec;28(12):3016-29. doi: 10.1007/s11095-011-0550-2. Epub 2011 Aug 5.
9
Epigenetics in prostate cancer: biologic and clinical relevance.前列腺癌中的表观遗传学:生物学和临床相关性。
Eur Urol. 2011 Oct;60(4):753-66. doi: 10.1016/j.eururo.2011.06.035. Epub 2011 Jun 22.
10
The significance of strong histone deacetylase 1 expression in the progression of prostate cancer.组蛋白去乙酰化酶 1 表达增强在前列腺癌进展中的意义。
Histopathology. 2011 Apr;58(5):773-80. doi: 10.1111/j.1365-2559.2011.03797.x. Epub 2011 Mar 25.